AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 211 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $374,000 | +77.3% | 37,445 | +128.9% | 0.00% | – |
| Q1 2019 | $211,000 | -94.5% | 16,356 | -92.2% | 0.00% | -100.0% |
| Q2 2017 | $3,849,000 | -15.9% | 209,192 | +3.1% | 0.00% | -20.0% |
| Q1 2017 | $4,575,000 | -28.6% | 202,887 | +10.2% | 0.01% | -28.6% |
| Q4 2016 | $6,404,000 | +212.1% | 184,029 | +256.3% | 0.01% | +133.3% |
| Q3 2015 | $2,052,000 | -96.0% | 51,657 | -93.0% | 0.00% | -94.7% |
| Q2 2015 | $50,842,000 | +77.9% | 736,197 | +40.8% | 0.06% | +78.1% |
| Q1 2015 | $28,574,000 | – | 522,752 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |